Skip to content
VenoStent logo

VenoStent

VenoStent is a YC Summer 2020 (S20) company. Based in Houston, TX, USA. Team of 17.

  • Medical Devices
  • 3D Printing

About VenoStent

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

VenoStent builds a bioabsorbable vascular wrap, SelfWrap, placed around blood vessels during dialysis access surgery to prevent site failure. Dialysis access sites fail in 50-60% of cases within the first year, forcing repeat procedures and reducing quality of life for end-stage renal disease patients. SelfWrap replaces the current standard of care, which offers no mechanical support to the vessel after surgery.

Go-to-market

VenoStent targets vascular surgeons and dialysis care providers, with a clinical trial underway to build the evidence base needed for hospital and health system adoption.

From the Y Combinator listing

How VenoStent describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Absorbable wrap for blood vessels

There are 10 million dialysis and bypass surgeries per year, but half of them fail. VenoStent saves lives with a wrap that goes around blood vessels during surgery so they don't fail.

Facts

Industry
Healthcare / Healthcare -> Medical Devices
Location
Houston, TX, USA
Team size
17
Status
Active
Stage
Growth

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works